当前位置: 首页 > 期刊 > 《中外健康文摘·临床医师》 > 2008年第3期
编号:11675858
施慧达联合康忻治疗原发性高血压临床疗效分析
http://www.100md.com 2008年3月1日 《中外健康文摘·临床医师》 2008年第3期
施慧达联合康忻治疗原发性高血压临床疗效分析

     【中图分类号】R322.4+4 【文献标识码】A 【文章编号】1672-5085(2008)03-0058-01

    【摘要】目的:探讨高血压的治疗方法,进一步了解高血压联合用药的必要性。方法:收集来我院就诊的75例原发性高血压患者,分为综合治疗组与单纯治疗组,综合治疗组(38例)应用施慧达和康忻治疗,单纯治疗组(37例)应用施慧达治疗,分析二种治疗方法对原发性高血压的疗效。结果:综合治疗组对原发性高血压治疗的有效率(97.37%)明显高单纯治疗组(81.08%)。结论:施慧达联合康忻治疗原发性高血压效果理想,适合在临床中推广应用。

    【关键词】高血压;施慧达;康忻;治疗

    The clinical analysis of essential hypertension treated by levamlodipine beslate and bisoprolol fumarate Xian Yuzhen

    【Abstract】Objective:To study the curative effect of essential hypertension treatment, further understand the necessity of combination drug therapy for hypertension. Methods: 75 cases were divided into two groups. One group(38 cases) was treated by levamlodipine beslate and bisoprolol fumarate. The other group(37cases) was treated by levamlodipine beslate. Results: The total rate of curative efficacy was obviously higher in the comprehensive treatment group(97.37%) than in the other group(81.08%). Conclusions: Efficacy of evamlodipine beslate and bisoprolol fumarate is was satisfied. The combination drug therapy is worthy of being recommended in patients with essential hypertension. ......

您现在查看是摘要页,全文长 4571 字符